The clinical operations team at PROMETRIKA provides research planning and execution services to support product development in pharmaceuticals, biologics and medical devices for companies around the world. Team leaders are responsible for project planning and management, including monitoring enrollment, research schedules, third party vendor management, budgeting and performance metrics. They also coordinate services related to data management, biostatistics and medical writing for data collection and analysis, internal and external reporting, and regulatory filings.
According to a research study by CMSInfo, spending on clinical trials in the United States reached $24 billion in 2005, and it is projected to rise to $32.1 billion by 2011. The Congressional Budget Office in the United States estimates that by 2003 the average cost to develop a drug that represents a new molecular entity (NME) reached $802 million and the development timeline for NME drugs required an average of 7.5 years of clinical stage research.
"Increasingly, clients are looking to us for new approaches involving electronic data capture and other technologies that can maximize research efficiency without compromising quality and accuracy. With Faith's experience in these areas, PROMETRIKA is better prepared than ever before to be a comprehensive resource to help our clients plan and execute strategic and successful clinical research programs," Ms. Stepanians added.
Founded in 2003, PROMETRIKA, LLC, is a full service contract research
organization with headquarters in Cambridge, MA. The company provides a
full range of clinical research services to pharmaceutical, biotechnology
and medical device companies. PROMETRIKA's team has managed hundreds of
clinical trials from Phase 1 pharmacokinetic crossover trials to Phase 4
long-term multi-center studies. The company has extensive experience in all
|SOURCE PROMETRIKA, LLC|
Copyright©2008 PR Newswire.
All rights reserved